Literature DB >> 20528512

The impact of increased utilization of HIV drugs on longevity and medical expenditure: an assessment based on aggregate US time-series data.

Frank R Lichtenberg1.   

Abstract

The objective of this Special Report is to estimate the medical cost per life-year gained from increased utilization of HIV drugs by estimating the impact of increased drug utilization on the life expectancy and drug and hospital expenditure of HIV/AIDS patients, using aggregate (US national-level) data for the period 1982-2001.

Entities:  

Year:  2006        PMID： 20528512     DOI： 10.1586/14737167.6.4.425

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN： 1473-7167            Impact factor:   2.217


  2 in total

1.  Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009.

Authors:  Dana P Goldman; Timothy Juday; Daniel Seekins; Mark T Linthicum; John A Romley
Journal:  Health Aff (Millwood)       Date:  2014-03       Impact factor: 6.301

2.  The quality of medical care, behavioral risk factors, and longevity growth.

Authors:  Frank R Lichtenberg
Journal:  Int J Health Care Finance Econ       Date:  2010-12-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.